《美國股市》道指升138點或0.4% 輝瑞升逾4%
美股上升,三大指數續創收市新高。企業季績理想推動投資情緒,市場觀望美聯儲會議。輝瑞(PFE.US)股價升4.1%,公司預期「復必泰」疫苗今年銷售達360億美元。道指高開21點後反覆上升,曾升175點見36,088點歷史新高,並首度於36,000點之上收市。
道瓊斯工業平均指數升138.79點或0.4%,收報36,052.63點。
標準普爾500指數升16.98點或0.4%,收報4,630.65點。
納斯達克指數升53.68點或0.3%,收報15,649.6點。
思科系統(CSCO.US)升2.7%,爲升幅最大道指成分股。安進藥廠(AMGN.US)升2.1%。陶氏(DOW.US)及高盛(GS.US)各升1.8%及1.7%。Visa(V.US)跌1.6%,爲跌幅最大道指成分股。電動車生產商特斯拉(TSLA.US)回吐3%。新冠疫苗生產商Moderna(MRNA.US)升3.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.